(107), constructed the atlas of breast cancer immune cells through single-cell sequencing technologies including scRNA-seq and scTCR/BCR-seq, revealing the diversity of immune cells and extensively characterizing the heterogeneity of immune cells in breast cancer tissues. This evidence concerns the gene BCR and breast carcinoma.